Senior insider sale
CEO and President at JOUNCE THERAPEUTICS, INC. — senior position signals high conviction
$51.3K
45K shares
What this filing means
MURRAY RICHARD /CA/ plans to sell 45K shares of JOUNCE THERAPEUTICS, INC. valued at approximately $51.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/9/2023ACC: 0001242935-23-000002
DirectorOfficer· CEO and President
Since Sep 2018
45K
Shares to sell
$51.3K
Approx. market value
81.67K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock units
(1)
1/6/2023
81.67KTotal acquired81.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/6/2023 | Vesting of restricted stock units (1) | 81.67K | — |
| Total | 81.67K | ||
Planned & Completed Dispositions1
Nasdaq Stock MarketPlanned
Units to sell
45K
Market value
$51.3K
1/9/2023
Total
Units
45K
Value
$51.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/9/2023 | 45K | $51.3K | Nasdaq Stock Market | Planned |
| Total | 45K | $51.3K | ||